Ectopic lipid storage in insulin-targeted organs, including the liver, promotes insulin resistance and its complications, including non-alcoholic fatty liver disease (NAFLD), which was reported in the literature in up to 83% of FPLD2 cases [16]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.